TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

LOG IN / REGISTER

LOG IN

Don’t have an account? Register here Give your organization full access to The Jakarta Post. Register here

HaloDoc

National 5 years ago

The time is right: COVID-19 gives more room for telemedicine to grow in Indonesia

One of the leading telemedicine platforms in Indonesia, Alodokter, has seen a spike in user traffic in recent months.

Health 5 years ago

Halodoc allows users to book COVID-19 tests

The company provides both rapid tests and polymerase chain reaction (PCR) tests, also known as swab tests.

City 5 years ago

COVID-19: Halodoc, Gojek to offer some Jakartans free drive-through rapid testing

Healthcare platform Halodoc and ride-hailing app Gojek in cooperation with Mitra Keluarga Hospital and Kemayoran Complex Management Center (PPKK) plan to offer free rapid COVID-19 testing to some Jakartans from April 10 to 17.

National 6 years ago

PREMIUM
With doctors only one chat away, telemedicine on the rise in Indonesia

Sick days have become easier as meeting doctors, access to medicine and other health care-related services are only one chat away.

Health 6 years ago

PREMIUM
Online doctor service key to combat rampant medical hoaxes

According to Communications and Information Ministry data, 182 out of 1,224 hoaxes spread between August 2018 and March 2019 were medical hoaxes.

Business 6 years ago

PREMIUM
Startups offer wider health access to people

Indonesia’s healthtech scene emerged in the late 2010s when entrepreneurs founded many of today’s notable players such as HaloDoc, Alodokter, Medigo and ProSehat. In August last year, some of these players banded together to form the Indonesian HealthTech Association.

follow our Social media

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Let us know what you think:

Enter at least 30 characters

0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.